Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study of Primary Tumor Radiotherapy Omitting Clinical Target Volume for Patients With Stage Ⅳ NSCLC

NCT04654520 is registered in ClinicalTrials.gov with Guizhou Medical University as lead sponsor.

NCT NCT04654520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04654520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study of Primary Tumor Radiotherapy Omitting Clinical Target Volume for Patients With Stage Ⅳ NSCLC
Lead sponsor
Guizhou Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
December 15, 2020
Completion date
May 31, 2022
Enrollment
290 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonsmall cell lung cancer, stage iv, radiotherapy